U.S. markets closed
  • S&P Futures

    3,433.25
    +10.50 (+0.31%)
     
  • Dow Futures

    28,194.00
    +94.00 (+0.33%)
     
  • Nasdaq Futures

    11,685.25
    +35.00 (+0.30%)
     
  • Russell 2000 Futures

    1,617.00
    +5.70 (+0.35%)
     
  • Crude Oil

    40.57
    -0.26 (-0.64%)
     
  • Gold

    1,906.60
    -5.10 (-0.27%)
     
  • Silver

    24.59
    -0.10 (-0.42%)
     
  • EUR/USD

    1.1773
    0.0000 (-0.00%)
     
  • 10-Yr Bond

    0.7610
    +0.0170 (+2.28%)
     
  • Vix

    29.18
    +1.77 (+6.46%)
     
  • GBP/USD

    1.2945
    +0.0005 (+0.04%)
     
  • USD/JPY

    105.5850
    +0.1550 (+0.15%)
     
  • BTC-USD

    11,704.42
    +647.41 (+5.86%)
     
  • CMC Crypto 200

    238.37
    +4.70 (+2.01%)
     
  • FTSE 100

    5,884.65
    -34.93 (-0.59%)
     
  • Nikkei 225

    23,660.08
    -11.05 (-0.05%)
     

Reflecting on Apollo Medical Holdings' (NASDAQ:AMEH) Share Price Returns Over The Last Year

Simply Wall St
·3 mins read

It's easy to match the overall market return by buying an index fund. When you buy individual stocks, you can make higher profits, but you also face the risk of under-performance. Unfortunately the Apollo Medical Holdings, Inc. (NASDAQ:AMEH) share price slid 17% over twelve months. That falls noticeably short of the market return of around 16%. We wouldn't rush to judgement on Apollo Medical Holdings because we don't have a long term history to look at. It's down 4.0% in the last seven days.

See our latest analysis for Apollo Medical Holdings

To quote Buffett, 'Ships will sail around the world but the Flat Earth Society will flourish. There will continue to be wide discrepancies between price and value in the marketplace...' By comparing earnings per share (EPS) and share price changes over time, we can get a feel for how investor attitudes to a company have morphed over time.

Even though the Apollo Medical Holdings share price is down over the year, its EPS actually improved. It's quite possible that growth expectations may have been unreasonable in the past.

It's surprising to see the share price fall so much, despite the improved EPS. So it's easy to justify a look at some other metrics.

Apollo Medical Holdings managed to grow revenue over the last year, which is usually a real positive. Since we can't easily explain the share price movement based on these metrics, it might be worth considering how market sentiment has changed towards the stock.

The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).

earnings-and-revenue-growth
earnings-and-revenue-growth

It's good to see that there was some significant insider buying in the last three months. That's a positive. That said, we think earnings and revenue growth trends are even more important factors to consider. You can see what analysts are predicting for Apollo Medical Holdings in this interactive graph of future profit estimates.

A Different Perspective

While Apollo Medical Holdings shareholders are down 17% for the year, the market itself is up 16%. While the aim is to do better than that, it's worth recalling that even great long-term investments sometimes underperform for a year or more. Putting aside the last twelve months, it's good to see the share price has rebounded by 1.3%, in the last ninety days. This could just be a bounce because the selling was too aggressive, but fingers crossed it's the start of a new trend. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Consider for instance, the ever-present spectre of investment risk. We've identified 2 warning signs with Apollo Medical Holdings , and understanding them should be part of your investment process.

There are plenty of other companies that have insiders buying up shares. You probably do not want to miss this free list of growing companies that insiders are buying.

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.